Fiscal Tax Blog

Uncategorized

Drug pricing should be near top of agenda at Trump-Takaichi meeting

President Donald Trump will soon host Japanese Prime Minister Sanae Takaichi at the White House, where the two leaders will seek to strengthen the United States-Japan alliance and boost both countries’ economies. The president can advance these goals simultaneously in healthcare by urging Takaichi to reform how her aging nation’s healthcare system pays for prescription drugs. For decades, Japan, the world’s fifth-largest economy, has artificially suppressed its spending on innovative medicines, effectively freeriding on U.S. rewards for innovation. The country’s government-run health system conducts annual pricing reviews and…

Uncategorized

Trump’s ‘most favored nation’ policy threatens US competitiveness with China

Congressional enactment of the “most favored nation” drug pricing policy urged by President Donald Trump in his State of the Union message would gravely harm American innovation, competitiveness, and national security in the emerging pharmaceutical technology race with China by crippling the market incentive system that has reliably propelled U.S. global leadership in this vital sector for decades. MFN policies are price-control schemes that establish caps on the costs of prescription drugs sold in the United States based on…

Uncategorized

Seniors Paid Billions in Extra Premiums Due to Alleged Medicare Overpayments

The average American senior’s Medicare premiums last year were about 10% higher, or more than $200 annually, because of alleged overpayments to private Medicare Advantage plans, congressional investigators found. Medicare Part B premiums that most seniors pay were partly pushed up by controversial health-insurer practices such as adding diagnoses to trigger higher payments, according to the Joint Economic Committee, a bipartisan group of lawmakers that advises Congress on financial matters.

Uncategorized

Could U.S. policy clinch China’s grip on biotech?

Health care policy often carries unintended consequences. The Inflation Reduction Act’s “pill penalty,” for example, gave small-molecule drugs — which often take the form of pills — a shorter window of exemption from Medicare price-setting than biologics, which investors say disincentivizes innovation in small-molecule medicines that have the potential to treat cancer, neurological diseases, and more. Another IRA provision limited price-negotiation exemptions only to orphan drugs approved to treat a single rare disease, discouraging follow-on…

Uncategorized

Voters Prioritize Insurance Company Accountability in Health Care Reform

Voters prioritize reforms targeting insurance companies — especially proposals that curb insurer steering, guarantee savings flow directly to patients, and increase upfront transparency on total and out-of-pocket costs. Reflecting these priorities, among four center-right positioning statements tested, the message emphasizing insurance company and middleman accountability performed best. Most voters also believe vertical integration in health care — particularly insurer ownership of providers — raises patient costs.

Uncategorized

Commitment to Seniors Applauds President Trump’s Call to Rein in Big Insurers, Warns Against Efforts to Codify “Most Favored Nation”

Washington, D.C. – February 25, 2026 – Commitment to Seniors, a project of American Commitment, applauds President Trump for addressing abusive insurer practices and urging lawmakers to rein in rising health care costs during last night’s State of the Union. However, we strongly oppose any effort to codify the administration’s Most Favored Nation (MFN) drug pricing proposal into law. By tying U.S. reimbursement rates to prices set by socialist-style foreign governments, MFN would undermine the…

Uncategorized

2025: Big Insurance’s $1.7 Trillion Year

In 2025, the seven biggest health insurance conglomerates: Collected almost $1.7 trillion in total revenues, $175 billion more than in 2024; Made more than $54 billion in profits; Covered 10 million fewer people than in 2024; Ramped up their self-dealing by steering more of their health plan enrollees to physician practices, clinics, pharmacy operations and other clinical businesses they now own

Uncategorized

Insurance Companies Bear the Blame

The cost of health insurance premiums is by far the biggest concern of voters when it comes to health care, both when specifically asked about health care costs and the state of health care in the United States overall. Out-of-pocket costs, waste, fraud, and abuse, prescription drug costs, and surprise bills rank as second-tier concerns. Most voters say insurers are more responsible for premiums and out-of-pocket costs, while voters more often blame the entire system…